BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32866566)

  • 1. Risk of Pneumonitis and Outcomes After Mediastinal Proton Therapy for Relapsed/Refractory Lymphoma: A PTCOG and PCG Collaboration.
    Tseng YD; Hoppe BS; Dedeckova K; Patel CG; Hill-Kayser CE; Miller DM; Maity A; Mendenhall NP; Mailhot Vega RB; Yock TI; Baliga S; Hess CB; Winkfield KM; Mohindra P; Rosen LR; Tsai H; Chang J; Hartsell WF; Plastaras JP
    Int J Radiat Oncol Biol Phys; 2021 Jan; 109(1):220-230. PubMed ID: 32866566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma.
    Pinnix CC; Smith GL; Milgrom S; Osborne EM; Reddy JP; Akhtari M; Reed V; Arzu I; Allen PK; Wogan CF; Fanale MA; Oki Y; Turturro F; Romaguera J; Fayad L; Fowler N; Westin J; Nastoupil L; Hagemeister FB; Rodriguez MA; Ahmed S; Nieto Y; Dabaja B
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):175-82. PubMed ID: 25863764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vital organ sparing with proton therapy for pediatric Hodgkin lymphoma: Toxicity and outcomes in 50 patients.
    Tringale KR; Modlin LA; Sine K; Forlenza CJ; Cahlon O; Wolden SL
    Radiother Oncol; 2022 Mar; 168():46-52. PubMed ID: 35101461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapy.
    Fox AM; Dosoretz AP; Mauch PM; Chen YH; Fisher DC; LaCasce AS; Freedman AS; Silver B; Ng AK
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):277-83. PubMed ID: 22019238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?
    Abou Yehia Z; Mikhaeel GN; Smith G; Pinnix CC; Milgrom SA; Tang C; Jiang W; Fanale MA; Oki Y; Shank JH; Horace T; Reddy J; Akhtari M; Gunther JR; Suki T; Allen PK; Turner S; Mawlawi O; Dabaja BS
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):951-958. PubMed ID: 27742539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation pneumonitis in pediatric Hodgkin lymphoma patients receiving radiation therapy to the chest.
    Lewis GD; Agrusa JE; Teh BS; Gramatges MM; Kothari V; Allen CE; Paulino AC
    Pract Radiat Oncol; 2018; 8(5):e364-e368. PubMed ID: 29730281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary dose tolerance in hemithorax radiotherapy for Ewing sarcoma of the chest wall: Are we overestimating the risk of radiation pneumonitis?
    Parekh AD; Indelicato DJ; Hoppe BS; Vega RBM; Rotondo RL; Bradley JA
    Pediatr Blood Cancer; 2021 Nov; 68(11):e29287. PubMed ID: 34398486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma.
    Koh ES; Sun A; Tran TH; Tsang R; Pintilie M; Hodgson DC; Wells W; Heaton R; Gospodarowicz MK
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):223-8. PubMed ID: 16904523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study.
    Hoppe BS; Flampouri S; Zaiden R; Slayton W; Sandler E; Ozdemir S; Dang NH; Lynch JW; Li Z; Morris CG; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1053-1059. PubMed ID: 24928256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy.
    Kharofa J; Cohen EP; Tomic R; Xiang Q; Gore E
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):238-43. PubMed ID: 22300564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of Mediastinal Lymphoma Patients for Proton Therapy Within the Proton Collaborative Group Registry: Concordance With the ILROG Guidelines.
    Tseng YD; Pankuch M; Mohindra P; McGee L; Rossi C; Flampouri S; Hajj C; Molitoris JK; Chang JH; Tsai H; Stevens C; Rosen L; Vargas C; Hartsell W
    Am J Clin Oncol; 2021 Jun; 44(6):269-274. PubMed ID: 33852456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical results of proton beam therapy for elderly patients with non-small cell lung cancer.
    Ono T; Nakamura T; Yamaguchi H; Azami Y; Takayama K; Suzuki M; Wada H; Kikuchi Y; Murakami M; Nemoto K
    Radiat Oncol; 2018 Feb; 13(1):19. PubMed ID: 29402290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma.
    Hoppe BS; Hill-Kayser CE; Tseng YD; Flampouri S; Elmongy HM; Cahlon O; Mendenhall NP; Maity A; McGee LA; Plastaras JP
    Ann Oncol; 2017 Sep; 28(9):2179-2184. PubMed ID: 28911093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial Report of a Prospective Dosimetric and Clinical Feasibility Trial Demonstrates the Potential of Protons to Increase the Therapeutic Ratio in Breast Cancer Compared With Photons.
    Bradley JA; Dagan R; Ho MW; Rutenberg M; Morris CG; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):411-421. PubMed ID: 26611875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee Collaboration.
    Baron JA; Wright CM; Maxwell R; Kim MM; Giap F; Vega RBM; Hoppe BS; LaRiviere MJ; Maity A; Plastaras JP; Paydar I
    Adv Radiat Oncol; 2023; 8(1):101090. PubMed ID: 36530648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of radiation techniques in the treatment of mediastinal lymphoma: from 3D conformal radiotherapy (3DCRT) to intensity-modulated RT (IMRT) using helical tomotherapy (HT): a single-centre experience and review of the literature.
    Besson N; Pernin V; Zefkili S; Kirova YM
    Br J Radiol; 2016; 89(1059):20150409. PubMed ID: 26744079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel.
    Barriger RB; Fakiris AJ; Hanna N; Yu M; Mantravadi P; McGarry RC
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1381-6. PubMed ID: 20231061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
    Allen AM; Czerminska M; Jänne PA; Sugarbaker DJ; Bueno R; Harris JR; Court L; Baldini EH
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):640-5. PubMed ID: 16751058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
    Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
    Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Low dose volume histogram analysis of the lungs in prediction of acute radiation pneumonitis in patients with esophageal cancer treated with three-dimensional conformal radiotherapy].
    Shen WB; Zhu SC; Gao HM; Li YM; Liu ZK; Li J; Su JW; Wan J
    Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):45-9. PubMed ID: 23648300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.